DK0604657T3 - Phosphonsyrediesterderivat - Google Patents

Phosphonsyrediesterderivat

Info

Publication number
DK0604657T3
DK0604657T3 DK93910361T DK93910361T DK0604657T3 DK 0604657 T3 DK0604657 T3 DK 0604657T3 DK 93910361 T DK93910361 T DK 93910361T DK 93910361 T DK93910361 T DK 93910361T DK 0604657 T3 DK0604657 T3 DK 0604657T3
Authority
DK
Denmark
Prior art keywords
phosphonic acid
acid diester
diester derivatives
derivatives
hyperlipidemia
Prior art date
Application number
DK93910361T
Other languages
English (en)
Inventor
Kazuyoshi Miyata
Yasuo Shoji
Yoshihiko Tsuda
Kazuhiko Tsutsumi
Yasuhide Inoue
Chieko Naba
Yasuhisa Kurogi
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of DK0604657T3 publication Critical patent/DK0604657T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503Five-membered rings
    • C07F9/6506Five-membered rings having the nitrogen atoms in positions 1 and 3
    • C07F9/65068Five-membered rings having the nitrogen atoms in positions 1 and 3 condensed with carbocyclic rings or carbocyclic ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/653Five-membered rings
    • C07F9/65324Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6539Five-membered rings
    • C07F9/6541Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK93910361T 1992-05-21 1993-05-20 Phosphonsyrediesterderivat DK0604657T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP12871192 1992-05-21
PCT/JP1993/000660 WO1993023409A1 (en) 1992-05-21 1993-05-20 Phosphonic diester derivative

Publications (1)

Publication Number Publication Date
DK0604657T3 true DK0604657T3 (da) 2000-04-17

Family

ID=14991544

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93910361T DK0604657T3 (da) 1992-05-21 1993-05-20 Phosphonsyrediesterderivat

Country Status (13)

Country Link
US (1) US5376665A (da)
EP (1) EP0604657B1 (da)
JP (1) JP2759228B2 (da)
KR (1) KR0185225B1 (da)
AT (1) ATE188704T1 (da)
AU (1) AU653681B2 (da)
CA (1) CA2113561C (da)
DE (1) DE69327572T2 (da)
DK (1) DK0604657T3 (da)
ES (1) ES2140456T3 (da)
PT (1) PT604657E (da)
TW (1) TW243451B (da)
WO (1) WO1993023409A1 (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW260664B (da) * 1993-02-15 1995-10-21 Otsuka Pharma Factory Inc
JP3533542B2 (ja) * 1994-03-08 2004-05-31 株式会社大塚製薬工場 ホスホン酸ジエステル誘導体
US5442118A (en) * 1994-04-22 1995-08-15 Sepracor, Inc. Asymmetric synthesis of (R)- and (S)-arylethanolamines from iminoketones
US6288100B1 (en) 1995-06-06 2001-09-11 American Home Products Corporation Benzimidazole derivatives
US5985858A (en) * 1995-12-27 1999-11-16 Otsuka Pharmaceutical Factory, Inc. Phosphonic diester derivatives
CA2259431A1 (en) * 1996-07-01 1998-01-08 Eli Lilly And Company Hypoglycemic and hypolipidemic compounds
EP0925063A4 (en) 1996-07-01 2000-12-27 Lilly Co Eli Blood-glucose-lowering and lipid-lowering compounds
JP2001515482A (ja) * 1997-03-07 2001-09-18 メタバシス・セラピューティクス・インコーポレイテッド フルクトース−1,6−ビスホスファターゼの新規なベンズイミダゾールインヒビター
AU6452098A (en) * 1997-03-07 1998-09-22 Metabasis Therapeutics, Inc. Novel purine inhibitors of fructose-1,6-bisphosphatase
EP1402895A1 (en) * 1997-03-07 2004-03-31 Metabasis Therapeutics, Inc. Benzimidazole inhibitors of fructose 1,6-biphosphatase
WO1999001454A1 (en) 1997-07-03 1999-01-14 Du Pont Pharmaceuticals Company Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
US6124463A (en) * 1998-07-02 2000-09-26 Dupont Pharmaceuticals Benzimidazoles as corticotropin release factor antagonists
US6365589B1 (en) 1998-07-02 2002-04-02 Bristol-Myers Squibb Pharma Company Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists
EP1303272B1 (en) 2000-06-21 2008-02-13 F. Hoffmann-La Roche Ag Benzothiazole derivatives for the treatment of alzheimer's disease and parkinson's disease
US20040029867A1 (en) * 2001-05-04 2004-02-12 Scarborough Robert M. Heterobicyclic sulfonamides and their use as platelet adp receptor inhibitors
WO2003030902A1 (en) 2001-10-09 2003-04-17 Tularik Inc. Imidazole derivates as anti-inflammatory agents
US6624163B2 (en) * 2001-11-29 2003-09-23 Hoffman-La Roche Inc. Benzothiazole derivatives
US7087761B2 (en) 2003-01-07 2006-08-08 Hoffmann-La Roche Inc. Cyclization process for substituted benzothiazole derivatives
RU2344132C2 (ru) * 2003-06-20 2009-01-20 Ф.Хоффманн-Ля Рош Аг 2-аминобензотиазолы в качестве обратных агонистов рецепторов cb1
EP1680431A1 (en) * 2003-10-17 2006-07-19 Rigel Pharmaceuticals, Inc. Benzothiazole and thiazole'5,5-b!pyridine compositions and their use as ubiquitin ligase inhibitors
AU2005247567B2 (en) 2004-05-24 2010-09-02 F. Hoffmann-La Roche Ag 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide
US7459563B2 (en) 2004-11-05 2008-12-02 Hoffmann-La Roche Inc. Process for the preparation of isonicotinic acid derivatives
BRPI0609719B8 (pt) 2005-03-23 2021-05-25 Hoffmann La Roche derivados de acetilenil-pirazol-pirimidina como antagonistas de mgbur2
BRPI0616571A2 (pt) 2005-09-27 2011-06-21 Hoffmann La Roche oxadiazolil pirazol-piridiminas como antagonistas de mglur2, processo para sua preparação, composição farmacêutica que os contém e uso dos mesmo
DE102007012284A1 (de) 2007-03-16 2008-09-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel
DE102007035333A1 (de) 2007-07-27 2009-01-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel
DE102007035334A1 (de) * 2007-07-27 2009-01-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel
DE102007042154A1 (de) 2007-09-05 2009-03-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Arylsulfonylaminomethyphosphonsäure-Derivate, deren Herstellung und deren Verwendung als Arzneimittel
EP2348857B1 (en) * 2008-10-22 2016-02-24 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
CN103168032A (zh) 2010-08-05 2013-06-19 安美基公司 抑制间变性淋巴瘤激酶的苯并咪唑和氮杂苯并咪唑化合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU523040B2 (en) * 1978-05-15 1982-07-08 Kanebo Limited Calcium -antagonistic composition
NZ234564A (en) * 1986-11-21 1991-04-26 Haessle Ab 1-substituted benzimidazoles and pharmaceutical compositions

Also Published As

Publication number Publication date
EP0604657B1 (en) 2000-01-12
AU653681B2 (en) 1994-10-06
WO1993023409A1 (en) 1993-11-25
AU4088793A (en) 1993-12-13
DE69327572T2 (de) 2000-06-21
CA2113561C (en) 1999-09-14
ATE188704T1 (de) 2000-01-15
TW243451B (da) 1995-03-21
ES2140456T3 (es) 2000-03-01
JP2759228B2 (ja) 1998-05-28
EP0604657A1 (en) 1994-07-06
KR0185225B1 (ko) 1999-05-15
PT604657E (pt) 2000-04-28
EP0604657A4 (en) 1995-03-15
CA2113561A1 (en) 1993-11-25
DE69327572D1 (de) 2000-02-17
US5376665A (en) 1994-12-27

Similar Documents

Publication Publication Date Title
DK0604657T3 (da) Phosphonsyrediesterderivat
NO976085D0 (no) Difenylmetylen-piperidin-derivater
ES2066000T3 (es) Compuestos derivados de pirimidinediona, metodo de produccion de los mismos y agentes antirritmicos que los contienen.
DE69325944T2 (de) s-Triazinderivate als Lichtschutzmittel
NO180407C (no) Anvendelse av 1,3-oksatiolannukleosidanaloger ved fremstilling av et medikament for behandling av hepatitt B
ATE93838T1 (de) Triphenylmethan-derivate.
FI935944A0 (fi) Pyratsolopyrimidin- samt pyrimidinylbisfosfonestrar som anti- inflammatorer
ATE117989T1 (de) Prostaglandinanaloge enthaltende lipidemulsion.
ES2106058T3 (es) Derivados de benzamida.
FI893682A (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,2,5-ditiatsosiinijohdannaisten valmistamiseksi
GR3007465T3 (da)
DE69123757D1 (de) Epoxysuccinamidsäurederivat
DK0541322T3 (da) 1-Alkyl-2-acyl-1,2-disulfonylhydraziner med antineoplastisk aktivitet
SE8704542D0 (sv) New derivatives of cysteine
FI890798A0 (fi) Foerfarande foer diacylering av foereningar som innehaoller tvao aromatiska kaernor.
ATE146472T1 (de) Umwandlungsverfahren von lorabef dihydrate in loracarbef monohydrate
DE3867494D1 (de) Fluor enthaltende vitamin-d2-derivate.
DK656889A (da) Azabicykliske derivater